en

PRODUCT DETAIL

Reverantza 20 mg/5 mg filmom obalené tablety

Code 9903D
MA number 58/0240/20-S
Product Form: tbl flm 56x20 mg/5 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DB Angiotensin II antagonists and calcium channel blockers
C09DB02 Olmesartan medoxomil and amlodipine
Shelf life: 51
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 18.12.2020
Validity: 18.12.2025
PIL: PIL_Reverantza_01/2023.pdf  
SPC: SPC_Reverantza_01/2023.pdf  
Safety feature Yes
Data update: 17.03.2022
eu-flag.png sk-flag.png